scholarly journals The changes of cholecystokinin and cannabinoid 1 peptide receptor in stomach and duodenum of Type 2 diabetic rats treated with dipeptidyl peptidase-4 inhibitor-sitagliptin.

2017 ◽  
Vol 10 (1) ◽  
pp. 15-22
Author(s):  
Zeynep Mine Coşkun ◽  
Gülay Nephan ◽  
Sezin Karabulut ◽  
Sema Bolkent
Keyword(s):  
Dipeptidyl Peptidase ◽  
Diabetic Rats ◽  
Dipeptidyl Peptidase 4 ◽  
Peptide Receptor ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Type 2 Diabetic

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

Metabolism ◽  
2013 ◽  
Vol 62 (3) ◽  
pp. 347-351 ◽  
Author(s):  
Noriko Satoh-Asahara ◽  
Yousuke Sasaki ◽  
Hiromichi Wada ◽  
Mayu Tochiya ◽  
Azusa Iguchi ◽  
...  
Keyword(s):  
Dipeptidyl Peptidase ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Anti Inflammatory ◽  
Type 2 Diabetic

scholarly journals The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice

2015 ◽  
Vol 35 (2) ◽  
pp. 676-682 ◽  
Author(s):  
NAOKI YORIFUJI ◽  
TAKUYA INOUE ◽  
MUNETAKA IGUCHI ◽  
KAORI FUJIWARA ◽  
KAZUKI KAKIMOTO ◽  
...  
Keyword(s):  
Dipeptidyl Peptidase ◽  
Diabetic Mice ◽  
Dipeptidyl Peptidase 4 ◽  
Colon Tumorigenesis ◽  
Mouse Colon ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document